Company intelligence / Profile preview

Xpress Biologics

Herstal / Milmort, Belgiumxpress-biologics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Xpress Biologics provides contract development and manufacturing services for recombinant proteins, antibody fragments, plasmid DNA, biosimilars, biobetters, and conjugated proteins. The company serves human/veterinary healthcare as well as diagnostics markets. It does not have its own drug pipeline or direct clinical results but enables client programs to progress from research through preclinical/clinical stages.

Modalities: Recombinant proteinAntibody fragmentPlasmid DNAConjugated proteinBiosimilarBiobetter
Industry: Contract Manufacturing Organization

Partnerships

Collaborates with academic institutions and biotech/pharma companies as clients/co-development partners.Now part of Sartorius/Polyplus group.

Beyond the preview

Go deeper on Xpress Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xpress Biologics.

Explore the full profile